BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 20524334)

  • 1. [Role and place of albumin dialysis in the treatment of patients with hepatic insufficiency].
    Kutepov DE; Pasechnik IN; Popov AV; Kontarev SI; Krylov VV
    Anesteziol Reanimatol; 2010; (2):53-8. PubMed ID: 20524334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Albumin dialysis (MARS therapy) in patients with hepatic graft dysfunction].
    Aleksandrova IV; Ermolov AS; Chzhao AV; Artamonov VV; Reĭ SI
    Anesteziol Reanimatol; 2008; (6):67-70. PubMed ID: 19227298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficiency of dialysis with albumin in the treatment of patients with advanced hepatic insufficiency: initial experience with the MARS system in Spain].
    Avilés J; Macía M; Morales S; Pérez F; Moreno A; Navarro J; Navazo L; García J
    Nefrologia; 2001; 21(4):376-85. PubMed ID: 11816514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial.
    Mitzner SR; Stange J; Klammt S; Risler T; Erley CM; Bader BD; Berger ED; Lauchart W; Peszynski P; Freytag J; Hickstein H; Loock J; Löhr JM; Liebe S; Emmrich J; Korten G; Schmidt R
    Liver Transpl; 2000 May; 6(3):277-86. PubMed ID: 10827226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Replacement therapy for hepatic failure syndrome].
    Iampol'skiĭ AF; Eremeeva LF
    Anesteziol Reanimatol; 2006; (6):26-30. PubMed ID: 17288262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of resistant pruritus from cholestasis with albumin dialysis: combined analysis of patients from three centers.
    Parés A; Herrera M; Avilés J; Sanz M; Mas A
    J Hepatol; 2010 Aug; 53(2):307-12. PubMed ID: 20580987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of extracorporeal blood purification methods: Molecular Adsorbent Recirculating System (MARS) for hepatic and renal function replacement].
    Marangoni R
    G Ital Nefrol; 2007; 24 Suppl 38():92-6. PubMed ID: 17922457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Extracorporeal methods of hematological correction in patients with acute liver insufficiency after cardiac surgery].
    Iarustovskiĭ MB; Abramian MV; Komardina EV; Rep'eva EV; Nazarova EI; Krotenko NP; Geptner RA
    Anesteziol Reanimatol; 2014; 59(5):4-10. PubMed ID: 25842933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is it possible to gain extra waiting time to liver transplantation in acute liver failure patients using albumin dialysis?
    Koivusalo AM; Kantola T; Arola J; Höckerstedt K; Kairaluoma P; Isoniemi H
    Ther Apher Dial; 2009 Oct; 13(5):413-8. PubMed ID: 19788458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of the hepatic encephalopathy scoring algorithm in a clinical trial of patients with cirrhosis and severe hepatic encephalopathy.
    Hassanein T; Blei AT; Perry W; Hilsabeck R; Stange J; Larsen FS; Brown RS; Caldwell S; McGuire B; Nevens F; Fontana R
    Am J Gastroenterol; 2009 Jun; 104(6):1392-400. PubMed ID: 19455117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Albumin-mediated peritoneal dialysis as method of restorational therapy in hepatic insufficiency].
    Rusyn VI; Shliakhta TIa; Rusyn AV; Rumiantsev KIe; Sheremet AP
    Klin Khir; 2005 Jul; (7):25-8. PubMed ID: 16255218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitis.
    Sen S; Mookerjee RP; Cheshire LM; Davies NA; Williams R; Jalan R
    J Hepatol; 2005 Jul; 43(1):142-8. PubMed ID: 15878216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A pilot study of using pure albumin as a dialysate in the treatment of liver failure].
    Liu Q; Peng L; Du Y; Li M; Jia N; Zou HQ
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Oct; 17(10):599-602. PubMed ID: 16259917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Peritoneal dialysis with allogenic hepatic cell suspension in treatment of hepatic insufficiency].
    Kardava I; Chutkerashvili K
    Georgian Med News; 2005 Apr; (121):75-7. PubMed ID: 15908732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of the molecular adsorbent recirculating system (MARS) albumin dialysis for the treatment of liver failure: a nursing perpective.
    McCready R
    Dynamics; 2009; 20(3):18-22. PubMed ID: 19953756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Albumin dialysis and Molecular Adsorbents Recirculating System (MARS) for acute Wilson's disease.
    Sen S; Felldin M; Steiner C; Larsson B; Gillett GT; Olausson M; Williams R; Jalan R
    Liver Transpl; 2002 Oct; 8(10):962-7. PubMed ID: 12360442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging indications for albumin dialysis.
    Sen S; Williams R; Jalan R
    Am J Gastroenterol; 2005 Feb; 100(2):468-75. PubMed ID: 15667509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive criteria for the outcome of patients with acute liver failure treated with the albumin dialysis molecular adsorbent recirculating system.
    Novelli G; Rossi M; Ferretti G; Pugliese F; Ruberto F; Lai Q; Novelli S; Piemonte V; Turchetti L; Morabito V; Annesini MC; Berloco PB
    Ther Apher Dial; 2009 Oct; 13(5):404-12. PubMed ID: 19788457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MARS: The ultimate warrior against pruritus of cholestasis?
    Chazouillères O
    J Hepatol; 2010 Aug; 53(2):228-9. PubMed ID: 20494469
    [No Abstract]   [Full Text] [Related]  

  • 20. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.